« Home « Kết quả tìm kiếm

Neuromuscular block


Tìm thấy 20+ kết quả cho từ khóa "Neuromuscular block"

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction

tailieu.vn

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction. In this review, indications for neuromuscular block, the challenge of neuromuscular monitoring and the practice of under-dosing of sugammadex as a potential cost-saving strategy are discussed.. Main body: Reversal of neuromuscular block is important to accelerate the spontaneous recovery of neuromuscular function.

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: An ex vivo laboratory study

tailieu.vn

for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers:. Background: Residual neuromuscular block at the end of surgery may compromise the patient’s safety. The risk of airway complications can be minimized through monitoring of neuromuscular function and reversal of neuromuscu- lar block if needed.

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: An ex vivo laboratory study

tailieu.vn

Pre-block effect of magnesium. To determine the pre-block effect of magnesium on re- versal of neuromuscular block, a single rocuronium dose (0.3 mg rocuronium for [Mg 2.

Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block

tailieu.vn

The high sensitivity of the algorithm, however, also im- plies the risk to overestimate residual neuromuscular block and therefore provoke overtreatment with its im- manent side effects.

Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: Case report and brief review of literature

tailieu.vn

Failure of reversion of neuromuscular block with sugammadex in patient with. myasthenia gravis: case report and brief review of literature. Background: Myasthenia gravis (MG) is a challenge for anesthesia management. This report shows that the use of rocuronium-sugammadex is not free from flaws and highlights the importance of cholinesterase inhibitors management and neuromuscular block monitoring in the perioperative period of myasthenic patients..

Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: A randomized clinical trial

tailieu.vn

Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate. neuromuscular block: a randomized clinical trial. Methods: Adults with BMI ≥ 40 kg/m 2 were randomized to 1 of 5 groups: M-neuromuscular block, sugammadex 2 mg/kg ABW. M-neuromuscular block, sugammadex 2 mg/kg IBW. D-neuromuscular block, sugammadex 4 mg/kg ABW. or D-neuromuscular block, sugammadex 4 mg/kg IBW.

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: A double blind prospective randomized controlled trial

tailieu.vn

The patients with a moderate block and sugammadex re- versal received a median of 40 mg of rocuronium after ini- tial neuromuscular blockade, a similar amount compared to the moderate block and neostigmine reversal group, who had a median of 45 mg (P = 0.454).. We were able to success- fully reverse the neuromuscular block in all patients with the mentioned doses of the reversal agents.

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: A retrospective observational study

tailieu.vn

Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. A survey of current management of neuromuscular block in the United States and Europe. Consensus statement on perioperative use of neuromuscular monitoring.. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain

tailieu.vn

In the past years, new pharmacological alternatives for reversal of neuromuscular blockade have been intro- duced. In clinical trials, sugammadex has been shown to pro- duce much more rapid and predictable reversal of neuromuscular block compared to neostigmine, in the absence of anti-muscarinic side effects and, in trials where quantitative neuromuscular monitoring was not. required, a steep reduction in the incidence of residual NMB .

Comparison of deep or moderate neuromuscular blockade for thoracoscopic lobectomy: A randomized controlled trial

tailieu.vn

The relationship of posttetanic count and train-of-four responses during recovery from intense cisatracurium induced neuromuscular blockade. Predicting recovery from deep neuromuscular block by rocuronium in the elderly. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.. Sugammadex: a review of neuromuscular blockade reversal..

Lidocaine combined with magnesium sulfate preserved hemodynamic stability during general anesthesia without prolonging neuromuscular blockade: A randomized, double-blind, controlled trial

tailieu.vn

The present study evaluated the effects of these drugs, isolated or combined, on hemodynamic parameters as well as on the cisatracurium-induced neuromuscular blockade (NMB)..

Comparison of neuromuscular blockade recovery co-administered with neostigmine and different doses of calcium gluconate: A randomized control trial

tailieu.vn

Advances in neurobiology of the neuromuscular junction: implications for the anesthesiologist.. Comparison of the TOFscan and the TOF-watch SX during recovery of neuromuscular function. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Effect of ionized calcium on the neuromuscular blocking actions of atracurium and vecuronium in the cat.

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: A systematic review

tailieu.vn

Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Baillard C, Clec ’ h C, Catineau J, Salhi F, Gehan G, Cupa M, et al.. Eikermann M, Vogt F, Herbstreit F, Vahid-Dastgerdi M, Zenge MO, Ochterbeck C, et al. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Residual neuromuscular blockade:. Moher D, Larissa S, Clarke M, Ghersi D, Liberati A, Petticrew M, et al..

Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: A prospective pilot trial

tailieu.vn

Neuromuscular block and current treatment strategies for its reversal in children. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Postoperative residual neuromuscular paralysis at an Australian tertiary children’s hospital. Current evidence for the use of sugammadex in children..

Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery

tailieu.vn

Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand. A survey of current management of neuromuscular block in the United States and Europe

Use of sugammadex in patients with neuromuscular disorders: A systematic review of case reports

tailieu.vn

Previous case reports have also described prolonged neuromuscular blockade similar to depolarizing block or a tonic response following the use of neostigmine in pa- tients with neuromuscular disorders [21]. Within our literature search, evidence was collected on the use of sugammadex in four main types of neuromuscular disorders:.

Preparing for the unexpected: Special considerations and complications after sugammadex administration

tailieu.vn

Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20). Sugammadex and neostigmine dose- finding study for reversal of shallow residual neuromuscular block.. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal.

Comparison of the trapezius and the adductor pollicis muscle as predictor of good intubating conditions: A randomized controlled trial

tailieu.vn

The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. Monitoring the onset of neuromuscular block at the orbicularis oculi can predict good intubating conditions during atracurium-induced neuromuscular block.. Comparison of intubating conditions after rapacuronium (org 9487) and

SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation

tailieu.vn

Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.. Residual neuromuscular block: lessons unlearned part I:. definitions, incidence, and adverse physiologic effects of residual neuromuscular block.